HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Prescriptives Magic Show Reappears With Four New SKUs

This article was originally published in The Rose Sheet

Executive Summary

Prescriptives Magic collection is expanding with four new products slated to debut in June. Like the original products, Concealing Wand System and three Special Effects Pencils employ synthetic layered tints and clear prisms to "restore luminosity and a youthful glow."

You may also be interested in...



Prescriptives Adds Potion To Fragrance Caldron; Magic Show Continues

Prescriptives Potion women's fragrance targets a younger consumer group attracted to the company's trendy light-diffusing Magic skin-enhancing line. Positioned to women ages 27-35, Potion will be launched worldwide in November.

Prescriptives Adds Potion To Fragrance Caldron; Magic Show Continues

Prescriptives Potion women's fragrance targets a younger consumer group attracted to the company's trendy light-diffusing Magic skin-enhancing line. Positioned to women ages 27-35, Potion will be launched worldwide in November.

Estee Lauder Puts "Spotlight" On New Visual Skin Care Category

Estee Lauder Spotlight Skin Tone Perfector is "the millennium's answer to fresh, luminescent skin," the company said. The first product under Estee Lauder's new visual skin category is set to launch in December.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS007543

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel